School of Medicine

Anthony H. Guarino, M.D., instructor of anesthesiology, is joining scientists from around the country to test the drug called CC-5013.

The target molecule, known as IKK, regulates processes that can trigger dramatic changes in cellular physiology.

Research has shown that the compound 17AAG has the unusual ability to simultaneously affect multiple proteins implicated in human cancers.

Researchers have found that the areas of the brain that young people use when daydreaming are the same areas that fail in people with Alzheimer’s.

The protein, Sirt1, is referred to as Sir2 in lower organisms, in which it has previously proven to be a key to aging and longevity.More medical news

Photo by Robert BostonIncoming medical students of the Class of 2009 and their guests watched the Cards beat Arizona at the dean’s annual welcoming party.

James B. Lowe III, M.D., chief of the Section of Cosmetic Surgery, admits he’s obsessed with detail. “When I’m in the operating room, every millimeter and every second counts,” he says. “It’s so important to be 100 percent focused in the OR. I go into this zone and nothing can distract me.” With every procedure […]

Clint’s DNA was used to sequence the chimp genome.Comparing the human genome to the chimpanzee genome has allowed scientists to identify changes in the human genetic code that were so advantageous that they rapidly became the norm throughout humanity. The areas of human DNA where these changes occurred are currently the subject of follow-up investigations to identify the potentially vital contributions they now make to human health and development.

Deborah C. Rubin, M.D., has been named director of the Master of Arts and Doctor of Medicine Program (M.A./M.D.) at the School of Medicine.

Taking into account that each of us has unique physical characteristics partly determined by variations in our genes, pharmacogenetics researchers at the School of Medicine are finding ways to personalize cancer treatments.